Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases

Journal of Surgical Oncology

Volumn 109, Issue 6, 2014, Pages 516-520

  Abbott, Daniel E ^a   Sohn, Vance Y ^b   Hanseman, Dennis ^a   Curley, Steven A ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

comparative effectiveness; liver surgery; resource utilization

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL LIVER METASTASIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; LAPAROTOMY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PORTAL VEIN EMBOLIZATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROBABILITY; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RETROSPECTIVE STUDY;

COMPARATIVE EFFECTIVENESS; LIVER SURGERY; RESOURCE UTILIZATION;

AGED; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION TREES; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84898772157     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23539     Document Type: Article

References (24)

1. Pawlik TM, Izzo F, Cohen DS, et al.: Combined resection and radiofrequency ablation for advanced hepatic malignancies: Results in 172 patients. Ann Surg Oncol 2003; 10: 1059-1069.
2. Abdalla EK, Barnett CC, Doherty D, et al.: Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137: 675-680; discussion 680-681.
3. Shindoh J, Truty MJ, Aloia TA, et al.: Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: Toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 2013; 216: 201-209.
4. Adam R, Delvart V, Pascal G, et al.: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 2004; 240: 644-657; discussion 657-658.
5. Cannon R, Ellis S, Hayes D, et al.: Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 2013; 107: 544-549.
6. Chun YS, Vauthey JN, Ribero D, et al.: Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: Perioperative safety and survival. J Gastrointest Surg 2007; 11: 1498-1504; discussion 1504-1505.
7. Wicherts DA, Miller R, de Haas RJ, et al.: Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 2008; 248: 994-1005.
8. Bilchik AJ, Faries M:, Radiofrequency ablation of hepatic malignancies: Inexpensive and minimally invasive but should it replace resection ? Ann Surg Oncol 2003; 10: 1002-1004.
9. Aloia TA, Vauthey JN, Loyer EM, et al.: Solitary colorectal liver metastasis: Resection determines outcome. Arch Surg 2006; 141: 460-466; discussion 466-467.
10. Abdalla EK, Vauthey JN, Ellis LM, et al.: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825; discussion 825-827.
11. Brouquet A, Abdalla EK, Kopetz S, et al.: High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome. J Clin Oncol 2011; 29: 1083-1090.
12. Abdalla EK, Bauer TW, Chun YS, et al.: Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: Expert consensus statements. HPB (Oxford) 2013; 15: 119-130.
13. Gold JS, Are C, Kornprat P, et al.: Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: Trends in treatment over time in 440 patients. Ann Surg 2008; 247: 109-117.
14. Shimada H, Tanaka K, Matsuo K:, Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg 2006; 391: 130-142.
15. Elias D, Santoro R, Ouellet JF, et al.: Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology 2004; 51: 1788-1791.
16. Munoz E, Munoz W, III, Wise L:, National and surgical health care expenditures, 2005-2025. Ann Surg 2010; 251: 195-200.
17. Mariotto AB, Yabroff KR, Shao Y, et al.: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103: 117-128.
18. Schrag D:, The price tag on progress-Chemotherapy for colorectal cancer. N Engl J Med 2004; 351: 317-319.
19. Hood VL, Weinberger SE:, High value, cost-conscious care: An international imperative. Eur J Intern Med 2012; 23: 495-498.
20. Smith TJ, Hillner BE:, Bending the cost curve in cancer care. N Engl J Med 2011; 364: 2060-2065.
21. Curley SA, Izzo F, Delrio P, et al.: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999; 230: 1-8.
22. U.S. Department of Health and Human Services: HCUPnet [cited 2012 September 1]; Available from: http://hcupnet.ahrq.gov/HCUPnet.jsp
23. U.S. Department of Health and Human Services: [cited 2012 September 1]; Available from: http://www.cms.org
24. Lee KH, Kim HO, Yoo CH, et al.: Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer. Korean J Gastroenterol 2012; 59: 218-223.